Prognostic value of immunocytochemical estimation of estrogen receptor (ER) and of pS2 estrogen-dependent protein in cells of mammary ductal carcinoma. Analysis of five-year course of the disease

Folia Histochemica et Cytobiologica

Volumn 39, Issue 2, 2001, Pages 143-144

  Surowiak, P ^a   Dziegiel, P ^a   Zabel, M ^a   Matkowski, R ^a   Kornafel, J ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Estrogen receptor; Immunocytochemistry; Mammary carcinoma; pS2

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; PARAFFIN; PROTEIN PS2; TAMOXIFEN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER STAGING; CANCER SURVIVAL; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL TIME;

EID: 0035027873     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Relationship of quantitative estrogen-receptor level and clinical response to chemotherapy in advanced breast cancer. An experimental analysis
2. Receptor heterogeneity of human breast cancer as measured by multiple intratumoral assays of estrogen and progesterone receptor
3. pNR-2/ pS2 immunohistochemical staining in breast cancer: Correlation with prognostic factors and endocrine response
4. Mechanism of action of the female sex hormones
5. Tamoxifen therapy in primary breast cancer: Biology, efficacy and side effect
6. Vorschlag zur einheitlichen definition eines immunreaktiven score (IRS) fuer den immunohistochemischen oestrogenrezeptor-nachweis (ER-ICA) im mammakarzinomgewebe
7. HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer